Scientific Backing
Glyconutrients and Science

Science is continuing to prove the powerful effects that glyconutrients have on the body. Their benefits are so wide-ranging that they often appear unrelated to each other, which is why they were never taken seriously by scientists before. In fact, researchers used to find the sugar-coatings a nuisance and would discard them, preferring to concentrate their studies on the proteins - long thought to be the the actual communicators for the cell. Proteins still play an important role in cell communication, but there are limits to the numbers of messages that they can send within a limited space.

For instance, two identical amino acids (proteins) can combine to form only one biochemical message, but two identical monosaccharides (sugars) can form 11 distinct molecules. Furthermore, 4 different amino acids can form only 24 distinct molecules; but 4 different saccharides can potentially combine into 35,560 different molecules called "tetrasaccharides". Each one of these 35,560 different shapes is potentially a distinct letter in the language of cells. Without the essential sugars, even proteins cannot be fully utilized by the cell.

Glyconutrient Interest in Medicine and Science

• Glyconutrients are now listed in the 2004 edition of the PDR for compromised immune systems.
• Harper's Biochemistry is the main biochemistry textbook required by doctors during their medical training. It now includes Glyconutrients in its teachings as having a vital role in health and healing. As of 1996, chapter 56 was edited to indicate there are now eight essential carbohydrates and not two as previously taught. Doctors, who graduated before this time, will not likely know of glyconutrients or their potential.
• In the March 23, 2001 issue of Science Magazine, 42 pages were dedicated to educating the science and medical community about Glyconutrients, Glycobiology and Glycoscience.
• Articles in Scientific American include: "Sweet Medicine: Building Better Drugs from Sugars" (July, 2002) and "Changing Cancer Cells' "Surface Sugars" can Inhibit Tumor Growth" (January 22, 2002).
• In the June 2002 issue of MD News, a 3-page article covered the science of sugars and featured its successes with such disorders as fibromyalgia, toxic shock, and diabetes.
• As of August 2003, Oxford University began focusing on the "clinical development of iminosugar derivatives as antiviral agents", particularly the hepatitis C virus.
• Dr. Gunter Blobel received the 1999 Nobel Prize for Medicine for his work in the new field of Glycobiology. In fact, four of the last eight Nobel Prizes for Medicine have dealt with the cellular communication process and its importance to health.
• In the July/August, 2002, issue of Advance for Managers of Respiratory Care included an article called "Glyconutrients Could Offer Novel Approach to Asthma".
• Dr. Ben Carson, a world-renowned professor of neurosurgery, oncology, plastic surgery, and pediatrics at John Hopkins University had a very aggressive type of cancer that reversed itself with the use of high dosages of glyconutrients.
• Dr. H.R. McDaniel, who spent 16 years exploring the therapeutic nature of Aloe vera, was invited to address a conference in 2000, on Comprehensive Cancer Care, which highlighted the latest and most promising techniques for cancer therapy. As a result of this appearance, he was invited to present the Glyconutrient principle before the Royal Society of Medicine in London, England on August 28, 2001, and later to the United Nations-sponsored 17th International Conference on Nutrition.
• Mizutani Foundation for Glycoscience of Japan promotes worldwide progress in glycoscience, especially those of glycoconjugates. The Foundation, along with the Seikagaku Corporation, promotes research and development in the field of glycoscience. At present, their major program is to award research grants to qualified glycoscientists.
• National Institute of Advanced Industrial Science and Technology. The Research Center for Glycoscience of Japan is a new AIST research center that became independent from the Institute of Molecular and Cell Biology but has a limited life of six fiscal years, from June 1, 2002, to March 31, 2008. With sixteen permanent researchers and about 100 others including technicians, collaborators from outside institutes, post-doctoral fellows, graduate and undergraduate students, and administrative staffs, they are working towards several goals, including the construction of a prototype machine for a sugar chain synthesizer and to promote industrial applications of glycoscience.